Nausea and vomiting
Drug research and approvals for nausea and vomiting: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 104 studies of nausea and vomiting are recruiting on ClinicalTrials.gov, Health Canada has authorized 14 drug trials for it since 2013, FDA has 0 approved and 1 open orphan designations naming it, and the EU has 6 authorised medicines for it.
- Recruiting worldwide: 104
- Trials authorized in Canada: 14
- FDA orphan approvals: 0
- EU medicines: 6
Recruiting Now
Newest start dates first, of 104 recruiting on ClinicalTrials.gov ↗- The Use of a Comfort Tote to Improve Recovery in Pediatric and Adolescent Patients After SurgeryNCT07632833 · Not applicable · Columbia University · starts Dec 1, 2026
- A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy AdultsNCT07868861 · Phase 1 · Nasus Pharma · starts Sep 15, 2026
- Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy VolunteersNCT07681076 · Phase 4 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · starts Sep 3, 2026
- Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV…NCT07638527 · Phase 4 · Faisalabad Medical University · starts Sep 1, 2026
- Opioid-Free Anesthesia in FESS: A Prospective ERAS StudyNCT07812389 · Not reported · Filiz Kaya · starts Aug 15, 2026
- A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative…NCT07709897 · Phase 2 · Fujian Shengdi Pharmaceutical Co., Ltd. · starts Aug 6, 2026
- Routine Antiemetic Prophylaxis for Nonfasted Parturients Undergoing Cesarean Sections Under Spinal AnesthesiaNCT07740577 · Phase 4 · Sanliurfa Education and Research Hospital · starts Jul 30, 2026
- HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World StudyNCT07874308 · Not reported · Sun Yat-sen University · starts Jul 15, 2026
- Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung CancerNCT07768124 · Not applicable · Xiu Huang · starts Jul 15, 2026
- Hyperemesis Gravidarum Risk Reduction With MetforminNCT07129473 · Phase 1 / Phase 2 · University of Southern California · starts Jul 13, 2026
Trials Authorized in Canada
The 10 newest of 14; search them all in Canada trials| Apr 15, 2026 | Prophylaxis for emetogenic radiotherapy with akynzeo (pret)NETUPITANT-PALONOSETRON | UNIVERSITY HEALTH NETWORK | Pending |
| Mar 30, 2026 | Effect of aprepitant on post-operative nausea and vomiting in otologic surgery: a pilot randomized controlled trialAPREPITANT | CIUSSS DU CENTRE-OUEST-DE-L’ILE-DE-MONTREAL, INSTITUTION OF SANTÉ QUEBEC | Pending |
| Dec 3, 2025 | Adding aprepitant to a multimodal strategy for preventing postoperative nausea and vomiting in high-risk patients undergoing outpatient surgeryAPREPITANT | SANTÉ QUÉBEC¿- CENTRE HOSPITALIER DE L’UNIVERSITÉ DE MONTRÉAL | Ongoing |
| Dec 7, 2023 | A randomized controlled trial comparing aprepitant to standard of care for postoperative nausea and vomiting prophylaxis in children undergoing scoliosis…APREPITANT | DR. MATHEW KIBERD | Ongoing |
| Jun 1, 2023 | Administration of aprepitant for the prevention of nausea and vomiting in pregnant women undergoingAPREPITANT | SANTÉ QUÉBEC¿- CENTRE HOSPITALIER DE L’UNIVERSITÉ DE MONTRÉAL | Pending |
| Feb 22, 2023 | Randomized, double-blind, phase 2/3 study of iv amisulpride as prevention of post-operative nausea and vomiting in pediatric patientsAMISULPRIDE (APD421) / ONDANSETRON | Acacia Pharma | Ongoing |
| Jan 11, 2017 | Randomized controlled trial of olanzapine for the control of chemotherapy-induced vomiting in children receiving chemotherapy for hematopoietic stem cell…OLANZAPINE | THE HOSPITAL FOR SICK CHILDREN | Ongoing |
| Jul 22, 2016 | A randomized trial of individualised care versus standard care for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting.OLANZAPINE | OTTAWA HOSPITAL RESEARCH INSTITUTE | Closed |
| Aug 18, 2015 | Randomised, double-blind, placebo-controlled study of apd421 (amisulpride for iv injection) as treatment of established postoperative nausea and vomiting, in…AMISULPRIDE (ADP421) | Acacia Pharma | Closed |
| Mar 4, 2015 | 5-ht3 antagonists (antiemetics) and cardiac safetyONDANSETRON | CHILD & FAMILY RESEARCH INSTITUTE | Closed |
FDA Orphan Designations
Approved first, then open designations, newest first| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Oct 14, 2015 | ondansetron inhalation powderPrevention of chemotherapy-induced nausea and vomiting due to highly emetogenic chemotherapy in pediatric patients (0 through 16 years of… | Luxena Pharmaceuticals, Inc. | Designated |
Medicines Authorised in the EU
Newest first| May 26, 2016 | Palonosetron Accordpalonosetron · generic | Accord Healthcare S.L.U. | EMA ↗ |
| May 27, 2015 | Akynzeonetupitant;palonosetron | Helsinn Birex Pharmaceuticals Ltd | EMA ↗ |
| Apr 20, 2012 | Sancusogranisetron | Grünenthal GmbH | EMA ↗ |
| Jan 11, 2008 | Ivemendfosaprepitant | Merck Sharp & Dohme B.V. | EMA ↗ |
| Mar 22, 2005 | Aloxipalonosetron | Helsinn Birex Pharmaceuticals Ltd. | EMA ↗ |
| Nov 11, 2003 | Emendaprepitant | Merck Sharp & Dohme B.V. | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA